Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/05/2009US20090275635 Screening method
11/05/2009US20090275634 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
11/05/2009US20090275632 Methods of diagnosis and treatment
11/05/2009US20090275631 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
11/05/2009US20090275630 Cosmetic composition comprising an imidopercarboxylic acid derivative and a n-acylated amino acid ester
11/05/2009US20090275629 Therapy for the treatment of disease
11/05/2009US20090275628 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments
11/05/2009US20090275627 Alpha2b and alpha2c agonists
11/05/2009US20090275626 Pharmaceutical composition for prevention or treatment of neurogenic pain
11/05/2009US20090275625 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-phenyl-thiazolidin-4-one; {2-[4-(2-([Z]-isopropylimino)-4-oxo-3-phenyl-thiazolidin-5-[Z]-ylidenemethyl)-phenoxy]-ethoxy}-acetic acid; immunosuppressant agents; multiple sclerosis, psoriasis
11/05/2009US20090275624 Inhibitors of cdc phosphatases
11/05/2009US20090275623 Alpha-amino acid derivatives and medicaments containing the same as an active ingredient
11/05/2009US20090275622 Nizatidine formulations
11/05/2009US20090275621 peroxisome proliferator-activated receptors (PPAR) modulators such as 5-(4-{2-[5-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-ethoxy}-phenyl)-3H-[1,3,4]oxadiazol-2-one, used for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization
11/05/2009US20090275620 Substituted 5- phenylamino- 1, 3, 4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
11/05/2009US20090275619 Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
11/05/2009US20090275618 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as cb1 receptor modulators
11/05/2009US20090275617 such as 3-[(1S,3R)-3-fluorocyclopentylamino]methyl-5-(5-fluoro-6-methylpyridin-3-yl)-1-isopropyl-4-methyl-1H-pyrazole, having opioid receptor antagonistic activity, used analgesics or for the treatment of diabetes, neurodegenerative diseases, drug abuse, hypotension, schizophrenia , dementia or obesity
11/05/2009US20090275616 Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues
11/05/2009US20090275615 Method of treating thermoregulatory disfunction with paroxetine
11/05/2009US20090275614 Methylphenidate Derivatives and Uses of Them
11/05/2009US20090275613 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009US20090275612 Compound With Antimalarial Activity And Antimalarial Drug Containing The Same As Active Ingredient
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275610 Tricyclic opioid modulators
11/05/2009US20090275609 Carboxamide Compounds and Methods for Using The Same
11/05/2009US20090275608 Methods of diagnosing and treating parp-mediated diseases
11/05/2009US20090275607 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
11/05/2009US20090275606 Heterocyclic Compounds as MEK Inhibitors
11/05/2009US20090275605 3,11 b-cis-Dihydrotetrabenazine for the Treatment of a Proliferative Disease or an Inflammatory Disease
11/05/2009US20090275604 M3 Muscarinic Acetylcholine Receptor Antagonists
11/05/2009US20090275603 NF- kB Inhibitors And Uses Thereof
11/05/2009US20090275602 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
11/05/2009US20090275600 Modified pyrimidine glucocorticoid receptor modulators
11/05/2009US20090275599 Therapeutic or prophylactic agent for multiple sclerosis
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009US20090275597 Methods of treating cns disorders
11/05/2009US20090275596 Treatment of Neurodegenerative Disorders with Thiourea Compounds
11/05/2009US20090275595 Method for reduction, stabilization and prevention of rupture of lipid rich plaque
11/05/2009US20090275594 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
11/05/2009US20090275593 3 Substituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors
11/05/2009US20090275592 Heterocyclic modulators of PKB
11/05/2009US20090275591 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitor
11/05/2009US20090275590 (1-azinone)-substituted pyridoindoles
11/05/2009US20090275588 Novel sulfonamide compounds
11/05/2009US20090275587 Methods of treating ischemic related conditions
11/05/2009US20090275586 Heterocyclic inhibitors of pde4
11/05/2009US20090275585 Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition
11/05/2009US20090275583 Antiviral compounds and use thereof
11/05/2009US20090275582 Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275580 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275579 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275578 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
11/05/2009US20090275577 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
11/05/2009US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009US20090275575 Benzophenone derivatives useful for inhibiting formation of microtubule
11/05/2009US20090275574 Novel compounds-300
11/05/2009US20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275571 Morpholinyl and pyrrolidinyl analogs
11/05/2009US20090275570 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/05/2009US20090275569 Benzotriazine Inhibitors of Kinases
11/05/2009US20090275568 Fused quinoline derivative and use thereof
11/05/2009US20090275567 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
11/05/2009US20090275566 Bace inhibitors
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275564 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/05/2009US20090275563 Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
11/05/2009US20090275562 Tolerability of mirtazapine and a second active by using them in combination
11/05/2009US20090275561 Compounds for the Treatment of Hepatitis C
11/05/2009US20090275560 Organic compounds
11/05/2009US20090275559 Chronotherapeutic formulations of modified-release calcium channel blocker anti-hypertensive drugs in combination with other anti-hypertensive drugs for 24-hour optimal treatment of hypertension, nocturnal hypertension, and/or hypertension with angina
11/05/2009US20090275558 Substituted sulfonamide compounds
11/05/2009US20090275557 Novel Composition for Treatment of Diseases Related to Activated Lymphocytes
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275555 Substituted indole ligands for the ORL-1 receptor
11/05/2009US20090275554 Aminocarboxylic acid derivative and medicinal use thereof
11/05/2009US20090275553 Dosage regimen of an s1p receptor agonist
11/05/2009US20090275552 Therapy for Treating Resistant Bacterial Infections
11/05/2009US20090275551 Fluvastatin for the treatment of patients with a history of muscle related side effects with other statins
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275549 Use of picoplatin to treat colorectal cancer
11/05/2009US20090275548 Compounds and methods for activated therapy
11/05/2009US20090275547 Metal complex phosphatidyl-inositol-3-kinase inhibitors
11/05/2009US20090275546 Diagnostic tests and personalized treatment regimes for cancer stem cells
11/05/2009US20090275545 Medicinal targeted local lipolysis
11/05/2009US20090275544 Method and kit for reducing the symptoms of peripheral vascular disease
11/05/2009US20090275543 Modified Glycosaminoglycans, Pharmaceutical Compositions and Methods for Oral Delivery Thereof
11/05/2009US20090275542 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
11/05/2009US20090275541 Method for treating neurocognitive dysfunction
11/05/2009US20090275540 Pre-Compacted Calcium-Containing Compositions
11/05/2009US20090275539 Nuclear Transcription Factors Regulators
11/05/2009US20090275538 Arylmethylidene heterocycles as novel analgesics
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275536 Antibacterial Agents
11/05/2009US20090275535 Antiviral phosphonate analogs
11/05/2009US20090275534 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/05/2009US20090275533 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009US20090275531 Method for producing starch networks and initial products
1 ... 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 ... 7860